This study will compare the effectiveness of cognitive behavioral therapy, antidepressant
medication, and a combination of the two for treating hypochondriasis.
This study will compare the effectiveness of cognitive behavioral therapy, antidepressant
medication, and a combination of the two for treating hypochondriasis.
Olanzapine in Patients With Advanced Cancer and Weight Loss
Completed
M.D. Anderson Cancer Center
Phase 1
2006-10-01
The goal of this clinical research study is to find the highest tolerable dose of the drug
Olanzapine that can be given to patients with advanced cancer who are experiencing weight
loss. Researchers want to find out if Olanzapine can help decrease weight loss in patients
who are experiencing it because of cancer. How this drug affects performance status,
cancer-related symptoms, and nutritional status in patients with advanced cancer will also be
studied.
Subcutaneous Olanzapine for Hyperactive or Mixed Delirium
Completed
M.D. Anderson Cancer Center
N/A
2005-06-01
The objective of this study is to determine the tolerability and safety of olanzapine
administered as a subcutaneous injection to hospitalized patients with hyperactive or mixed
delirium.
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Completed
Eli Lilly and Company
Phase 4
2009-04-01
The main goal of this study is to help answer the following research question(s) and not to
treat the child's illness.
- Can this study drug make children with bipolar depression feel better?
- Does this study drug work better than a placebo (sugar pill)?
- Does this study drug cause side effects in children who take it?
- Is this drug safe to use in children? (The study drug is a mixture of olanzapine and
fluoxetine)
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.